Relief Therapeutics Holding (XSWX:RLF) Change In Receivables : CHF0.13 Mil (TTM As of Dec. 2023)

View and export this data going back to 2013. Start your Free Trial

What is Relief Therapeutics Holding Change In Receivables?

Relief Therapeutics Holding's change in receivables for the quarter that ended in Dec. 2023 was CHF-0.17 Mil. It means Relief Therapeutics Holding's Accounts Receivable increased by CHF0.17 Mil from Jun. 2023 to Dec. 2023 .

Relief Therapeutics Holding's change in receivables for the fiscal year that ended in Dec. 2023 was CHF0.13 Mil. It means Relief Therapeutics Holding's Accounts Receivable declined by CHF0.13 Mil from Dec. 2022 to Dec. 2023 .

Relief Therapeutics Holding's Accounts Receivable for the quarter that ended in Dec. 2023 was CHF1.17 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Relief Therapeutics Holding's Days Sales Outstanding for the six months ended in Dec. 2023 was 71.00.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Relief Therapeutics Holding's liquidation value for the six months ended in Dec. 2023 was CHF-8.45 Mil.

Relief Therapeutics Holding Change In Receivables Historical Data

The historical data trend for Relief Therapeutics Holding's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Relief Therapeutics Holding Change In Receivables Chart

Relief Therapeutics Holding Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Receivables

Get a 7-Day Free Trial

-0.04

-0.21

-0.02

0.13

Relief Therapeutics Holding Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Change In Receivables	Get a 7-Day Free Trial															-	0.17	-0.19	0.30	-0.17

Relief Therapeutics Holding Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was CHF0.13 Mil.

Relief Therapeutics Holding (XSWX:RLF) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Relief Therapeutics Holding's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	1.171	/	3.01	*	91
=	71.00

2. In Ben Graham's calculation of liquidation value, Relief Therapeutics Holding's accounts receivable are only considered to be worth 75% of book value:

Relief Therapeutics Holding's liquidation value for the quarter that ended in Dec. 2023 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	14.556	-	24.162	+	0.75 * 1.171	+	0.5 * 0.557
=	-8.45

Relief Therapeutics Holding Change In Receivables Related Terms

Thank you for viewing the detailed overview of Relief Therapeutics Holding's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Relief Therapeutics Holding (XSWX:RLF) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Relief Therapeutics Holding SA (XSWX:RLF) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

RLFTY:USA RLFTF:USA RLFz:UK

Address

Avenue de Secheron 15, Fondation EIP, Batiment, Geneva, CHE, CH-1202

Website

https://www.relieftherapeutics.com

Relief Therapeutics Holding SA is engaged in the research, development, and commercialization of biopharmaceutical products. It mainly develops drugs of natural human origin. It has a focus on commercial products and the development program pipeline is focused on three main areas: rare genetic, metabolic disorders, rare connective tissue disorders, and rare lung diseases. Geographically group generates the majority of its revenue from Europe.

Relief Therapeutics Holding (XSWX:RLF) Headlines

No Headlines